Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 824

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease

Open access
Gershlick, Anthony H., Khan, Jamal Nasir, Kelly, Damian J., Greenwood, John P., Sasikaran, Thiagarajah, Curzen, Nick, Blackman, Daniel J., Dalby, Miles, Fairbrother, Kathryn L., Banya, Winston, Wang, Duolao, Flather, Marcus, Hetherington, Simon L., Kelion, Andrew D., Talwar, Suneel, Gunning, Mark, Hall, Roger, Swanton, Howard, McCann, Gerry P. · 2015 · Journal of the American College of Cardiology

Abstract

BACKGROUND: The optimal management of patients found to have multivessel disease while undergoing primary percutaneous coronary intervention (P-PCI) for ST-segment elevation myocardial infarction is uncertain. OBJECTIVES: CvLPRIT (Complete versus Lesion-only Primary PCI trial) is a U.K. open-label randomized study comparing complete revascularization at index admission with treatment of the infarct-related artery (IRA) only. METHODS: After they provided verbal assent and underwent coronary angiography, 296 patients in 7 U.K. centers were randomized through an interactive voice-response program to either in-hospital complete revascularization (n = 150) or IRA-only revascularization (n = 146). Complete revascularization was performed either at the time of P-PCI or before hospital discharge. Randomization was stratified by infarct location (anterior/nonanterior) and symptom onset (≤ 3 h or >3 h). The primary endpoint was a composite of all-cause death, recurrent myocardial infarction (MI), heart failure, and ischemia-driven revascularization within 12 months. RESULTS: Patient groups were well matched for baseline clinical characteristics. The primary endpoint occurred in 10.0% of the complete revascularization group versus 21.2% in the IRA-only revascularization group (hazard ratio: 0.45; 95% confidence interval: 0.24 to 0.84; p = 0.009). A trend toward benefit was seen early after complete revascularization (p = 0.055 at 30 days). Although there was no significant reduction in death or MI, a nonsignificant reduction in all primary endpoint components was seen. There was no reduction in ischemic burden on myocardial perfusion scintigraphy or in the safety endpoints of major bleeding, contrast-induced nephropathy, or stroke between the groups. CONCLUSIONS: In patients presenting for P-PCI with multivessel disease, index admission complete revascularization significantly lowered the rate of the composite primary endpoint at 12 months compared with treating only the IRA. In such patients, inpatient total revascularization may be considered, but larger clinical trials are required to confirm this result and specifically address whether this strategy is associated with improved survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.12.038

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 824

Metadata

Authors
Gershlick, A. H., Khan, J. N., Kelly, D. J., Greenwood, J. P., Sasikaran, T., Curzen, N., Blackman, D. J., Dalby, M., Fairbrother, K. L., Banya, W., Wang, D., Flather, M., Hetherington, S. L., Kelion, A. D., Talwar, S., Gunning, M., Hall, R., Swanton, H., & McCann, G. P.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2015-03
Volume
65
Issue
10
Pages
963-972
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1995734689
Cited by
824
References
19
FWCI
98.77
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease. https://app.cochat.ai/papers/10.1016/j.jacc.2014.12.038
The paper
Gershlick, A. H., Khan, J. N., Kelly, D. J., Greenwood, J. P., Sasikaran, T., Curzen, N., Blackman, D. J., Dalby, M., Fairbrother, K. L., Banya, W., Wang, D., Flather, M., Hetherington, S. L., Kelion, A. D., Talwar, S., Gunning, M., Hall, R., Swanton, H., & McCann, G. P. (2015). Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2014.12.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.